PSMA therapy<\/span> in Germany<\/h1><\/div>PSMA-targeted therapy for prostate cancer: from accurate diagnosis to innovative treatment<\/h4><\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/rrk-zentrum.de\/en\/wp-content\/uploads\/sites\/2\/2024\/09\/img_onkologija_senologija_gematologija_v_germanii-1.jpg\" "\\"img_onkologija_senologija_gematologija_v_germanii\\"")
<\/span><\/div><\/div><\/div><\/div><\/div>PSMA therapy is a breakthrough method of radionuclide treatment of metastatic prostate cancer, especially effective in castration-resistant forms. The RheinRegio Klinik Zentrum uses advanced technology using lutetium-177 (\u00b9\u2077\u2077Lu-PSMA), which precisely targets cancer cells while minimizing the impact on healthy tissue.<\/span><\/p>\n<\/div><\/div><\/div>What is PSMA therapy?<\/span><\/h2><\/div>PSMA (prostate-specific membrane antigen) is a protein that is produced in large quantities by prostate cancer cells in 90% of cases. The method is based on targeted effects:<\/span><\/p>\n\n- The radiopharmaceutical (\u00b9\u2077\u2077Lu-PSMA) binds to PSMA antigens.<\/span>
\n<\/span><\/li>\n- Lutetium-177 beta radiation destroys tumors and metastases.<\/span><\/li>\n<\/ul>\n
Advantages over chemotherapy:<\/strong><\/h3>\n\n- Targeted effect only on cancer cells.<\/span>
\n<\/span><\/li>\n- Fewer side effects (no systemic damage).<\/span>
\n<\/span><\/li>\n- Effective in resistant forms of prostate cancer.<\/span><\/li>\n<\/ul>\n<\/div>
Indications for PSMA therapy<\/span><\/h2><\/div>The method is used when:<\/h3>\n\n- Metastatic prostate cancer (bones, lymph nodes, liver).<\/li>\n
- Castration-resistant adenocarcinoma (CRPC).<\/li>\n
- Relapses after hormonal\/chemotherapy.<\/li>\n
- Ineffectiveness of other methods.<\/li>\n<\/ul>\n
Contraindications:<\/h3>\n\n- Severe renal failure.<\/li>\n
- Low PSMA expression (confirmed by PET-CT).<\/li>\n<\/ul>\n<\/div><\/div><\/div>
Each direction is supervised by advanced oncologists.<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Find out the cost of treatment<\/h2><\/div>To find out the approximate cost of treatment, answer a few questions and we will contact you!<\/span><\/p>\n<\/div>\n\n<\/p>
<\/ul><\/div>\n
PSMA-targeted therapy for prostate cancer: from accurate diagnosis to innovative treatment<\/h4><\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>PSMA therapy is a breakthrough method of radionuclide treatment of metastatic prostate cancer, especially effective in castration-resistant forms. The RheinRegio Klinik Zentrum uses advanced technology using lutetium-177 (\u00b9\u2077\u2077Lu-PSMA), which precisely targets cancer cells while minimizing the impact on healthy tissue.<\/span><\/p>\n<\/div><\/div><\/div>What is PSMA therapy?<\/span><\/h2><\/div>PSMA (prostate-specific membrane antigen) is a protein that is produced in large quantities by prostate cancer cells in 90% of cases. The method is based on targeted effects:<\/span><\/p>\n\n- The radiopharmaceutical (\u00b9\u2077\u2077Lu-PSMA) binds to PSMA antigens.<\/span>
\n<\/span><\/li>\n- Lutetium-177 beta radiation destroys tumors and metastases.<\/span><\/li>\n<\/ul>\n
Advantages over chemotherapy:<\/strong><\/h3>\n\n- Targeted effect only on cancer cells.<\/span>
\n<\/span><\/li>\n- Fewer side effects (no systemic damage).<\/span>
\n<\/span><\/li>\n- Effective in resistant forms of prostate cancer.<\/span><\/li>\n<\/ul>\n<\/div>
Indications for PSMA therapy<\/span><\/h2><\/div>The method is used when:<\/h3>\n\n- Metastatic prostate cancer (bones, lymph nodes, liver).<\/li>\n
- Castration-resistant adenocarcinoma (CRPC).<\/li>\n
- Relapses after hormonal\/chemotherapy.<\/li>\n
- Ineffectiveness of other methods.<\/li>\n<\/ul>\n
Contraindications:<\/h3>\n\n- Severe renal failure.<\/li>\n
- Low PSMA expression (confirmed by PET-CT).<\/li>\n<\/ul>\n<\/div><\/div><\/div>
Each direction is supervised by advanced oncologists.<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Find out the cost of treatment<\/h2><\/div>To find out the approximate cost of treatment, answer a few questions and we will contact you!<\/span><\/p>\n<\/div>\n\n<\/p>
<\/ul><\/div>\n
<\/span><\/div><\/div><\/div><\/div><\/div>PSMA therapy is a breakthrough method of radionuclide treatment of metastatic prostate cancer, especially effective in castration-resistant forms. The RheinRegio Klinik Zentrum uses advanced technology using lutetium-177 (\u00b9\u2077\u2077Lu-PSMA), which precisely targets cancer cells while minimizing the impact on healthy tissue.<\/span><\/p>\n<\/div><\/div><\/div> PSMA (prostate-specific membrane antigen) is a protein that is produced in large quantities by prostate cancer cells in 90% of cases. The method is based on targeted effects:<\/span><\/p>\n Each direction is supervised by advanced oncologists.<\/p>\n<\/div><\/div><\/div><\/div><\/div> To find out the approximate cost of treatment, answer a few questions and we will contact you!<\/span><\/p>\n<\/div>\n <\/p> What is PSMA therapy?<\/span><\/h2><\/div>
\n
\n<\/span><\/li>\nAdvantages over chemotherapy:<\/strong><\/h3>\n
\n
\n<\/span><\/li>\n
\n<\/span><\/li>\nIndications for PSMA therapy<\/span><\/h2><\/div>
The method is used when:<\/h3>\n
\n
Contraindications:<\/h3>\n
\n
Find out the cost of treatment<\/h2><\/div>
<\/ul><\/div>\n